Prevalence of Oral Human Papillomavirus Infection among Youth, Sweden
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Prevalence of Oral Human Papillomavirus Infection among Youth, Sweden
  • Published Date:

    Sep 2012

  • Source:
    Emerg Infect Dis. 18(9):1468-1471.
Filetype[PDF-180.71 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 306.82 KB]
    Personal Author:
    Ramqvist, Torbjörn; Dalianis, Tina;
    Published Date:
    Nov 2010
    Source:
    Emerg Infect Dis. 16(11):1671-1677.
    Description:
    A growing body of research shows that human papillomavirus (HPV) is a common and increasing cause of oropharyngeal squamous cell carcinoma (OSCC). Thus, the International Agency for Research against Cancer has acknowledged HPV as a risk factor for OS...
    File Type:
    Filetype[PDF - 306.82 KB]
  2. Filetype[PDF - 211.82 KB]
    Personal Author:
    Cook, Erin E.; Gershman, Susan T.; Kim, Jane J.; Tamimi, Rulla M.; Klevens, R. Monina; Holmes, Michelle D.;
    Published Date:
    March 01 2018
    Source:
    Cancer Causes Control. 29(4-5):435-443
    Description:
    PurposeTo understand trends in the incidence and mortality of two human papillomavirus (HPV)-associated cancers, cervical and oropharyngeal cancer, in Massachusetts.MethodsFrom 2004–2014, the Massachusetts Cancer Registry recorded 3,996 incident ca...
    File Type:
    Filetype[PDF - 211.82 KB]
  3. Filetype[PDF - 1.33 MB]
    Personal Author:
    Kumar, D.; Unger, E. R.; Panicker, G.; Medvedev, P.; Wilson, L.; Humar, A.;
    Published Date:
    Jul 09 2013
    Source:
    Am J Transplant. 13(9):2411-2417.
    Description:
    Solid organ transplant recipients are at risk of morbidity from human papillomavirus (HPV)-related diseases. Quadrivalent HPV vaccine is recommended for posttransplant patients but there are no data on vaccine immunogenicity. We determined the immuno...
    File Type:
    Filetype[PDF - 1.33 MB]
  4. Filetype[PDF - 111.58 KB]
    Personal Author:
    Hernandez, Brenda Y.; Wilkens, Lynne R.; Zhu, Xuemei; Thompson, Pamela; McDuffie, Katharine; Shvetsov, Yurii B.; Kamemoto, Lori E.; Killeen, Jeffrey; Ning, Lily; Goodman, Marc T.;
    Published Date:
    Jun 2008
    Source:
    Emerg Infect Dis. 14(6):888-894.
    Description:
    We examined the transmission of human papillomavirus (HPV) in 25 heterosexual, monogamous couples (25 men, 25 women), followed up over an average of 7.5 months. A total of 53 heterosexual transmission events were observed among 16 couples (14 male-to...
    File Type:
    Filetype[PDF - 111.58 KB]
  5. Filetype[PDF - 506.86 KB]
    Personal Author:
    Oliver, Sara E.; Unger, Elizabeth R.; Lewis, Rayleen; McDaniel, Darius; Gargano, Julia W.; Steinau, Martin; Markowitz, Lauri E.;
    Published Date:
    Sep 01 2017
    Source:
    J Infect Dis. 216(5):594-603.
    Description:
    BackgroundHuman papillomavirus (HPV) vaccine was recommended in 2006 for routine vaccination of US females aged 11–12 years. Most vaccine used through 2014 was quadrivalent vaccine (4vHPV), which prevents HPV-6, -11, -16, and -18 infection. To eval...
    File Type:
    Filetype[PDF - 506.86 KB]